1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Ferric Carboxymaltose 1.2.3 Iron Sucrose 1.2.4 Iron Dextran 1.2.5 Others 1.3 Market by Application 1.3.1 Global Intravenous (IV) Iron Therapy Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Nephrology 1.3.3 Gynecology & Obstetrics 1.3.4 Gastroenterology 1.3.5 Oncology 1.3.6 Cardiology 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Intravenous (IV) Iron Therapy Market Size (2017-2028) 2.2 Intravenous (IV) Iron Therapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Intravenous (IV) Iron Therapy Market Size by Region (2017-2022) 2.4 Global Intravenous (IV) Iron Therapy Market Size Forecast by Region (2023-2028) 2.5 Global Top Intravenous (IV) Iron Therapy Countries Ranking by Market Size 3 Intravenous (IV) Iron Therapy Competitive by Company 3.1 Global Intravenous (IV) Iron Therapy Revenue by Players 3.1.1 Global Intravenous (IV) Iron Therapy Revenue by Players (2017-2022) 3.1.2 Global Intravenous (IV) Iron Therapy Market Share by Players (2017-2022) 3.2 Global Intravenous (IV) Iron Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Intravenous (IV) Iron Therapy Revenue 3.4 Global Intravenous (IV) Iron Therapy Market Concentration Ratio 3.4.1 Global Intravenous (IV) Iron Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Iron Therapy Revenue in 2021 3.5 Global Intravenous (IV) Iron Therapy Key Players Head office and Area Served 3.6 Key Players Intravenous (IV) Iron Therapy Product Solution and Service 3.7 Date of Enter into Intravenous (IV) Iron Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Intravenous (IV) Iron Therapy Breakdown Data by Type 4.1 Global Intravenous (IV) Iron Therapy Historic Revenue by Type (2017-2022) 4.2 Global Intravenous (IV) Iron Therapy Forecasted Revenue by Type (2023-2028) 5 Global Intravenous (IV) Iron Therapy Breakdown Data by Application 5.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Application (2017-2022) 5.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) 6.2 North America Intravenous (IV) Iron Therapy Revenue by Type (2017-2028) 6.3 North America Intravenous (IV) Iron Therapy Revenue by Application (2017-2028) 6.4 North America Intravenous (IV) Iron Therapy Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) 7.2 Europe Intravenous (IV) Iron Therapy Revenue by Type (2017-2028) 7.3 Europe Intravenous (IV) Iron Therapy Revenue by Application (2017-2028) 7.4 Europe Intravenous (IV) Iron Therapy Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) 8.2 Asia Pacific Intravenous (IV) Iron Therapy Revenue by Type (2017-2028) 8.3 Asia Pacific Intravenous (IV) Iron Therapy Revenue by Application (2017-2028) 8.4 Asia Pacific Intravenous (IV) Iron Therapy Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) 9.2 Latin America Intravenous (IV) Iron Therapy Revenue by Type (2017-2028) 9.3 Latin America Intravenous (IV) Iron Therapy Revenue by Application (2017-2028) 9.4 Latin America Intravenous (IV) Iron Therapy Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) 10.2 Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Type (2017-2028) 10.3 Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Application (2017-2028) 10.4 Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Intravenous (IV) Iron Therapy Products and Services 11.1.4 Sanofi Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.1.5 Sanofi Intravenous (IV) Iron Therapy SWOT Analysis 11.1.6 Sanofi Recent Developments 11.2 Allergan 11.2.1 Allergan Company Details 11.2.2 Allergan Business Overview 11.2.3 Allergan Intravenous (IV) Iron Therapy Products and Services 11.2.4 Allergan Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.2.5 Allergan Intravenous (IV) Iron Therapy SWOT Analysis 11.2.6 Allergan Recent Developments 11.3 AMAG Pharmaceuticals 11.3.1 AMAG Pharmaceuticals Company Details 11.3.2 AMAG Pharmaceuticals Business Overview 11.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Products and Services 11.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.3.5 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy SWOT Analysis 11.3.6 AMAG Pharmaceuticals Recent Developments 11.4 Dalichi Sankyo 11.4.1 Dalichi Sankyo Company Details 11.4.2 Dalichi Sankyo Business Overview 11.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Products and Services 11.4.4 Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.4.5 Dalichi Sankyo Intravenous (IV) Iron Therapy SWOT Analysis 11.4.6 Dalichi Sankyo Recent Developments 11.5 Luitpold Pharmaceuticals 11.5.1 Luitpold Pharmaceuticals Company Details 11.5.2 Luitpold Pharmaceuticals Business Overview 11.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Products and Services 11.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.5.5 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy SWOT Analysis 11.5.6 Luitpold Pharmaceuticals Recent Developments 11.6 Pharmacosmos 11.6.1 Pharmacosmos Company Details 11.6.2 Pharmacosmos Business Overview 11.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Products and Services 11.6.4 Pharmacosmos Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.6.5 Pharmacosmos Intravenous (IV) Iron Therapy SWOT Analysis 11.6.6 Pharmacosmos Recent Developments 11.7 Takeda Pharmaceutical 11.7.1 Takeda Pharmaceutical Company Details 11.7.2 Takeda Pharmaceutical Business Overview 11.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Products and Services 11.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) 11.7.5 Takeda Pharmaceutical Intravenous (IV) Iron Therapy SWOT Analysis 11.7.6 Takeda Pharmaceutical Recent Developments 12 Intravenous (IV) Iron Therapy Market Dynamics 12.1 Intravenous (IV) Iron Therapy Market Trends 12.2 Intravenous (IV) Iron Therapy Market Drivers 12.3 Intravenous (IV) Iron Therapy Market Challenges 12.4 Intravenous (IV) Iron Therapy Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Ferric Carboxymaltose Table 3. Key Players of Iron Sucrose Table 4. Key Players of Iron Dextran Table 5. Key Players of Others Table 6. Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Intravenous (IV) Iron Therapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 8. Global Intravenous (IV) Iron Therapy Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Intravenous (IV) Iron Therapy Revenue Market Share by Region (2017-2022) Table 10. Global Intravenous (IV) Iron Therapy Revenue by Players (2017-2022) & (US$ Million) Table 11. Global Intravenous (IV) Iron Therapy Market Share by Players (2017-2022) Table 12. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Therapy as of 2021) Table 13. Ranking of Global Top Intravenous (IV) Iron Therapy Companies by Revenue (US$ Million) in 2021 Table 14. Global 5 Largest Players Market Share by Intravenous (IV) Iron Therapy Revenue (CR5 and HHI) & (2017-2022) Table 15. Key Players Headquarters and Area Served Table 16. Key Players Intravenous (IV) Iron Therapy Product Solution and Service Table 17. Date of Key Manufacturers Enter into Intravenous (IV) Iron Therapy Market Table 18. Mergers & Acquisitions, Expansion Plans Table 19. Global Intravenous (IV) Iron Therapy Market Size by Type (2017-2022) & (US$ Million) Table 20. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2017-2022) Table 21. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 22. Global Intravenous (IV) Iron Therapy Revenue Market Share by Type (2023-2028) Table 23. Global Intravenous (IV) Iron Therapy Market Size by Application (2017-2022) & (US$ Million) Table 24. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2017-2022) Table 25. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 26. Global Intravenous (IV) Iron Therapy Revenue Market Share by Application (2023-2028) Table 27. North America Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) & (US$ Million) Table 28. North America Intravenous (IV) Iron Therapy Revenue by Type (2017-2022) & (US$ Million) Table 29. North America Intravenous (IV) Iron Therapy Revenue by Type (2023-2028) & (US$ Million) Table 30. North America Intravenous (IV) Iron Therapy Revenue by Application (2017-2022) & (US$ Million) Table 31. North America Intravenous (IV) Iron Therapy Revenue by Application (2023-2028) & (US$ Million) Table 32. North America Intravenous (IV) Iron Therapy Revenue by Country (2017-2022) & (US$ Million) Table 33. North America Intravenous (IV) Iron Therapy Revenue by Country (2023-2028) & (US$ Million) Table 34. Europe Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) & (US$ Million) Table 35. Europe Intravenous (IV) Iron Therapy Revenue by Type (2017-2022) & (US$ Million) Table 36. Europe Intravenous (IV) Iron Therapy Revenue by Type (2023-2028) & (US$ Million) Table 37. Europe Intravenous (IV) Iron Therapy Revenue by Application (2017-2022) & (US$ Million) Table 38. Europe Intravenous (IV) Iron Therapy Revenue by Application (2023-2028) & (US$ Million) Table 39. Europe Intravenous (IV) Iron Therapy Revenue by Country (2017-2022) & (US$ Million) Table 40. Europe Intravenous (IV) Iron Therapy Revenue by Country (2023-2028) & (US$ Million) Table 41. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) & (US$ Million) Table 42. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Type (2017-2022) & (US$ Million) Table 43. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Type (2023-2028) & (US$ Million) Table 44. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Application (2017-2022) & (US$ Million) Table 45. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Application (2023-2028) & (US$ Million) Table 46. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Region (2017-2022) & (US$ Million) Table 47. Asia Pacific Intravenous (IV) Iron Therapy Revenue by Region (2023-2028) & (US$ Million) Table 48. Latin America Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) & (US$ Million) Table 49. Latin America Intravenous (IV) Iron Therapy Revenue by Type (2017-2022) & (US$ Million) Table 50. Latin America Intravenous (IV) Iron Therapy Revenue by Type (2023-2028) & (US$ Million) Table 51. Latin America Intravenous (IV) Iron Therapy Revenue by Application (2017-2022) & (US$ Million) Table 52. Latin America Intravenous (IV) Iron Therapy Revenue by Application (2023-2028) & (US$ Million) Table 53. Latin America Intravenous (IV) Iron Therapy Revenue by Country (2017-2022) & (US$ Million) Table 54. Latin America Intravenous (IV) Iron Therapy Revenue by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Company (2020-2022) & (US$ Million) Table 56. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Intravenous (IV) Iron Therapy Revenue by Country (2023-2028) & (US$ Million) Table 62. Sanofi Company Details Table 63. Sanofi Business Overview Table 64. Sanofi Intravenous (IV) Iron Therapy Product and Services Table 65. Sanofi Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 66. Sanofi Intravenous (IV) Iron Therapy SWOT Analysis Table 67. Sanofi Recent Developments Table 68. Allergan Company Details Table 69. Allergan Business Overview Table 70. Allergan Intravenous (IV) Iron Therapy Product and Services Table 71. Allergan Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 72. Allergan Intravenous (IV) Iron Therapy SWOT Analysis Table 73. Allergan Recent Developments Table 74. AMAG Pharmaceuticals Company Details Table 75. AMAG Pharmaceuticals Business Overview Table 76. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Product and Services Table 77. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 78. AMAG Pharmaceuticals Intravenous (IV) Iron Therapy SWOT Analysis Table 79. AMAG Pharmaceuticals Recent Developments Table 80. Dalichi Sankyo Company Details Table 81. Dalichi Sankyo Business Overview Table 82. Dalichi Sankyo Intravenous (IV) Iron Therapy Product and Services Table 83. Dalichi Sankyo Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 84. Dalichi Sankyo Intravenous (IV) Iron Therapy SWOT Analysis Table 85. Dalichi Sankyo Recent Developments Table 86. Luitpold Pharmaceuticals Company Details Table 87. Luitpold Pharmaceuticals Business Overview Table 88. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Product and Services Table 89. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 90. Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy SWOT Analysis Table 91. Luitpold Pharmaceuticals Recent Developments Table 92. Pharmacosmos Company Details Table 93. Pharmacosmos Business Overview Table 94. Pharmacosmos Intravenous (IV) Iron Therapy Product and Services Table 95. Pharmacosmos Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 96. Pharmacosmos Intravenous (IV) Iron Therapy SWOT Analysis Table 97. Pharmacosmos Recent Developments Table 98. Takeda Pharmaceutical Company Details Table 99. Takeda Pharmaceutical Business Overview Table 100. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Product and Services Table 101. Takeda Pharmaceutical Intravenous (IV) Iron Therapy Revenue in Intravenous (IV) Iron Therapy Business (2017-2022) & (US$ Million) Table 102. Takeda Pharmaceutical Intravenous (IV) Iron Therapy SWOT Analysis Table 103. Takeda Pharmaceutical Recent Developments Table 104. Intravenous (IV) Iron Therapy Market Trends Table 105. Intravenous (IV) Iron Therapy Market Drivers Table 106. Intravenous (IV) Iron Therapy Market Challenges Table 107. Intravenous (IV) Iron Therapy Market Restraints Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Global Intravenous (IV) Iron Therapy Sales Market Share by Type: 2021 VS 2028 Figure 2. Ferric Carboxymaltose Features Figure 3. Iron Sucrose Features Figure 4. Iron Dextran Features Figure 5. Others Features Figure 6. Global Intravenous (IV) Iron Therapy Sales Market Share by Application: 2021 VS 2028 Figure 7. Nephrology Case Studies Figure 8. Gynecology & Obstetrics Case Studies Figure 9. Gastroenterology Case Studies Figure 10. Oncology Case Studies Figure 11. Cardiology Case Studies Figure 12. Others Case Studies Figure 13. Intravenous (IV) Iron Therapy Report Years Considered Figure 14. Global Intravenous (IV) Iron Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Intravenous (IV) Iron Therapy Market Size 2017-2028 (US$ Million) Figure 16. Global Intravenous (IV) Iron Therapy Market Size Market Share by Region: 2021 VS 2028 Figure 17. Global Intravenous (IV) Iron Therapy Revenue Market Share by Region in 2017 VS 2022 Figure 18. Global Top 10 Intravenous (IV) Iron Therapy Countries Ranking by Market Size (US$ Million) in 2021 Figure 19. Global Intravenous (IV) Iron Therapy Market Share by Players in 2021 Figure 20. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Therapy as of 2021) Figure 21. The Top 10 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2021 Figure 22. North America Intravenous (IV) Iron Therapy Revenue Market Share by Company in 2021 Figure 23. North America Intravenous (IV) Iron Therapy Revenue Market Share by Type (2017-2028) Figure 24. North America Intravenous (IV) Iron Therapy Revenue Market Share by Application (2017-2028) Figure 25. North America Intravenous (IV) Iron Therapy Revenue Share by Country (2017-2028) Figure 26. U.S. Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 27. Canada Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 28. Europe Intravenous (IV) Iron Therapy Revenue Market Share by Company in 2021 Figure 29. Europe Intravenous (IV) Iron Therapy Revenue Market Share by Type (2017-2028) Figure 30. Europe Intravenous (IV) Iron Therapy Revenue Market Share by Application (2017-2028) Figure 31. Europe Intravenous (IV) Iron Therapy Revenue Share by Country (2017-2028) Figure 32. Germany Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 33. France Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 34. U.K. Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 35. Italy Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 36. Russia Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 37. Asia Pacific Intravenous (IV) Iron Therapy Revenue Market Share by Company in 2021 Figure 38. Asia Pacific Intravenous (IV) Iron Therapy Revenue Market Share by Type (2017-2028) Figure 39. Asia Pacific Intravenous (IV) Iron Therapy Revenue Market Share by Application (2017-2028) Figure 40. Asia Pacific Intravenous (IV) Iron Therapy Revenue Share by Region (2017-2028) Figure 41. China Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 42. Japan Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 43. South Korea Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 44. India Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 45. Australia Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 46. Taiwan Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 47. Indonesia Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 48. Thailand Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 49. Malaysia Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 50. Philippines Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 51. Vietnam Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 52. Latin America Intravenous (IV) Iron Therapy Revenue Market Share by Company in 2021 Figure 53. Latin America Intravenous (IV) Iron Therapy Revenue Market Share by Type (2017-2028) Figure 54. Latin America Intravenous (IV) Iron Therapy Revenue Market Share by Application (2017-2028) Figure 55. Latin America Intravenous (IV) Iron Therapy Revenue Share by Country (2017-2028) Figure 56. Mexico Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 57. Brazil Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 58. Argentina Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 59. Middle East and Africa Intravenous (IV) Iron Therapy Revenue Market Share by Company in 2021 Figure 60. Middle East and Africa Intravenous (IV) Iron Therapy Revenue Market Share by Type (2017-2028) Figure 61. Middle East and Africa Intravenous (IV) Iron Therapy Revenue Market Share by Application (2017-2028) Figure 62. Middle East and Africa Intravenous (IV) Iron Therapy Revenue Share by Country (2017-2028) Figure 63. Turkey Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 64. Saudi Arabia Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 65. UAE Intravenous (IV) Iron Therapy Revenue (2017-2028) & (US$ Million) Figure 66. Sanofi Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 67. Allergan Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 68. AMAG Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 69. Dalichi Sankyo Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 70. Luitpold Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 71. Pharmacosmos Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 72. Takeda Pharmaceutical Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2017-2022) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

Sanofi Allergan AMAG Pharmaceuticals Dalichi Sankyo Luitpold Pharmaceuticals Pharmacosmos Takeda Pharmaceutical